Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development

Open access

Abstract

BACKGROUND: Autophagy has emerged as a critical homeostatic mechanism in T lymphocytes, influencing proliferation and differentiation. Autophagy in B cells has been less studied, but genetic deficiency causes impairment of early and late developmental stages OBJECTIVES: To explore the role of autophagy in the pathogenesis of human and murine lupus, a disease in which B cells are critical effectors of pathology. METHODS: Autophagy was assessed using multiple techniques in NZB/W and control mice, and in patients with systemic lupus erythematosus (SLE) compared to healthy controls. We evaluated the phenotype of the B cell compartment in Vav-Atg7(-/-) mice in vivo, and examined human and murine plasmablast formation following inhibition of autophagy. RESULTS: We found activation of autophagy in early developmental and transitional stages of B cell development in a lupus mouse model even before disease onset, and which progressively increased with age. In human disease, again autophagy was activated compared with healthy controls, principally in naïve B cells. B cells isolated from Vav-Atg7(F/F) mice failed to effectively differentiate into plasma cells following stimulation in vitro. Similarly, human B cells stimulated in the presence of autophagy inhibition did not differentiate into plasmablasts. CONCLUSIONS: Our data suggest activation of autophagy is a mechanism for survival of autoreactive B cells, and also demonstrate that it is required for plasmablast differentiation, processes that induce significant cellular stress. The implication of autophagy in two major pathogenic pathways in SLE suggests the potential to use inhibition of autophagy as a novel treatment target in this frequently severe autoimmune disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2013-204343

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Autophagy in murine lupus. Autophagy in splenic NZB/W CD19+ B cells was compared with control C57BL/6 mice. (A) Representative multispectral imaging flow cytometry (MIFC) images of B cells with high and low numbers of LC3+ autophagosomes. (B) Example distributions of LC3+ punctae in diseased versus control mice at 13 weeks of age, with gating of autophagy-positive cells (defined as ≥7 spots per cell). There are increased numbers of LC3+ autophagosomes in the CD19+ B cells of NZB/W compared with control mice at 13 weeks (post-disease onset) (C). The number of autophagosomes measured using autophagosomotropic dye (D) or MIFC (E) increases with age, but a difference between the mice is present even at 4 weeks, before disease has developed. There was no difference in autophagosomotropic dye uptake in CD4+ T cells, at 13 weeks (F). Each data point represents an individual mouse. The horizontal bars denote mean. (G) There is decreased basal p62 expression, measured by intracellular FACS in splenic CD19+ B and CD19+/−CD138+ plasma cells in 13-week-old NZB/W mice. To demonstrate accumulation of the autophagic substrate p62, isolated splenocytes were incubated in complete RPMI with 100 nM bafilomycin A1 for 3 h (H). n=5 mice per group. Fold change in p62 MFI compared with untreated cells is shown. *p<0.05; p<0.01; ***p<0.001.
Figure 1 Autophagy in murine lupus. Autophagy in splenic NZB/W CD19+ B cells was compared with control C57BL/6 mice. (A) Representative multispectral imaging flow cytometry (MIFC) images of B cells with high and low numbers of LC3+ autophagosomes. (B) Example distributions of LC3+ punctae in diseased versus control mice at 13 weeks of age, with gating of autophagy-positive cells (defined as ≥7 spots per cell). There are increased numbers of LC3+ autophagosomes in the CD19+ B cells of NZB/W compared with control mice at 13 weeks (post-disease onset) (C). The number of autophagosomes measured using autophagosomotropic dye (D) or MIFC (E) increases with age, but a difference between the mice is present even at 4 weeks, before disease has developed. There was no difference in autophagosomotropic dye uptake in CD4+ T cells, at 13 weeks (F). Each data point represents an individual mouse. The horizontal bars denote mean. (G) There is decreased basal p62 expression, measured by intracellular FACS in splenic CD19+ B and CD19+/−CD138+ plasma cells in 13-week-old NZB/W mice. To demonstrate accumulation of the autophagic substrate p62, isolated splenocytes were incubated in complete RPMI with 100 nM bafilomycin A1 for 3 h (H). n=5 mice per group. Fold change in p62 MFI compared with untreated cells is shown. *p<0.05; p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 2 Autophagosome density in mouse B cell subsets. Distribution of CytoID MFI in B cell subsets from bone marrow (BM) and spleens of 13-week-old NZB/W mice and age matched controls. Pre-B (CD19+IgM−IgD−), immature B (BM Imm, CD19+IgD−IgM+), mature B (BM Mat, CD19+IgD+IgM+), T1 (CD19+IgM+ IgD−CD23−CD21−), T2 (CD19+IgM+ IgD+CD23+CD21+), marginal zone (MZ, CD19+IgM+IgD−CD23−CD21hi), follicular (FO, CD19+IgM−IgD+CD23hiCD21+), and BM plasma cell (CD19+/−CD138+) subsets are illustrated. n=5 mice per group. Box and whisker plots denote maximum and minimum, IQR, and median. *p<0.05; **p<0.01; ***p<0.001.
Figure 2 Autophagosome density in mouse B cell subsets. Distribution of CytoID MFI in B cell subsets from bone marrow (BM) and spleens of 13-week-old NZB/W mice and age matched controls. Pre-B (CD19+IgM−IgD−), immature B (BM Imm, CD19+IgD−IgM+), mature B (BM Mat, CD19+IgD+IgM+), T1 (CD19+IgM+ IgD−CD23−CD21−), T2 (CD19+IgM+ IgD+CD23+CD21+), marginal zone (MZ, CD19+IgM+IgD−CD23−CD21hi), follicular (FO, CD19+IgM−IgD+CD23hiCD21+), and BM plasma cell (CD19+/−CD138+) subsets are illustrated. n=5 mice per group. Box and whisker plots denote maximum and minimum, IQR, and median. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 3 Autophagy in systemic lupus erythematosus (SLE) patients versus healthy controls. (A–C) Representative images of CD19+ B cells, CD4+ T cells, and CD14+ monocytes with high and low numbers of LC3+ punctae, and comparison with healthy controls. CD19+ B cell LC3+ puncta count is correlated with SELENA-SLEDAI disease activity index (D). (E) Increased autophagic flux in SLE patients. Isolated CD19+ B cells from patients were incubated with 10 μM chloroquine in complete RPMI media for 2 h, and then analysed by multispectral imaging flow cytometry. Each point represents one individual patient or healthy donor. **p<0.01; ***p<0.001.
Figure 3 Autophagy in systemic lupus erythematosus (SLE) patients versus healthy controls. (A–C) Representative images of CD19+ B cells, CD4+ T cells, and CD14+ monocytes with high and low numbers of LC3+ punctae, and comparison with healthy controls. CD19+ B cell LC3+ puncta count is correlated with SELENA-SLEDAI disease activity index (D). (E) Increased autophagic flux in SLE patients. Isolated CD19+ B cells from patients were incubated with 10 μM chloroquine in complete RPMI media for 2 h, and then analysed by multispectral imaging flow cytometry. Each point represents one individual patient or healthy donor. **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 4 Differential autophagy in human B cell subsets. (A) The increase in autophagosome density seen in CD19+ B cells with multispectral imaging flow cytometry is also demonstrated using autophagosomotropic dye. (B) Gating strategy for naïve (CD27−IgD+), memory (CD27+IgD−), and plasmablast (CD27++IgD−) B cells, and differential autophagy by subset (C). (D) Example histogram of p62 MFI in naïve B cells of systemic lupus erythematosus (red line) compared with control (blue line). (E) Differential p62 expression in B cell subsets. *p<0.05; ***p<0.001.
Figure 4 Differential autophagy in human B cell subsets. (A) The increase in autophagosome density seen in CD19+ B cells with multispectral imaging flow cytometry is also demonstrated using autophagosomotropic dye. (B) Gating strategy for naïve (CD27−IgD+), memory (CD27+IgD−), and plasmablast (CD27++IgD−) B cells, and differential autophagy by subset (C). (D) Example histogram of p62 MFI in naïve B cells of systemic lupus erythematosus (red line) compared with control (blue line). (E) Differential p62 expression in B cell subsets. *p<0.05; ***p<0.001.CC BY · PubMed Central
Figure 5 Effects of autophagy inhibition on plasma cell differentiation. (A) B cells from Vav-Atg7−/− or control mice were stimulated with LPS (10 μg/mL) and IL-4 (10 ng/mL) for 72 h. The percentage CD19+CD138+ plasma cells is shown (B). There was decreased viability following the culture period, as assessed by exclusion of viability dye (C), and decreased secretion of IgM antibody (D). (E) B cells from healthy human donors were stimulated with ODN2006 (5 μM), IL-10 (50 ng/mL), IL-15 (10 ng/mL), and monoclonal mouse anti-CD40 L (1 μg/mL) for 72 h in the presence or absence of the autophagy inhibitor 3-methyladenine (5 mM). The percentage CD19+IgD−CD38++ plasmablasts following culture is shown (F), as is cell proliferation by carboxyfluorescein diacetate succinimidyl ester dilution (G). There is higher mitochondrial mass in Vav-Atg7−/− B cells, measured by MitoTracker Deep Red and Green (H) and (I), compared with control mice. (A–D) are representative of two independent experiments with n=5 mice per group. (E and G) are representative of three individual healthy donors. (H-I) n=5 per group. *p<0.05; **p<0.01.
Figure 5 Effects of autophagy inhibition on plasma cell differentiation. (A) B cells from Vav-Atg7−/− or control mice were stimulated with LPS (10 μg/mL) and IL-4 (10 ng/mL) for 72 h. The percentage CD19+CD138+ plasma cells is shown (B). There was decreased viability following the culture period, as assessed by exclusion of viability dye (C), and decreased secretion of IgM antibody (D). (E) B cells from healthy human donors were stimulated with ODN2006 (5 μM), IL-10 (50 ng/mL), IL-15 (10 ng/mL), and monoclonal mouse anti-CD40 L (1 μg/mL) for 72 h in the presence or absence of the autophagy inhibitor 3-methyladenine (5 mM). The percentage CD19+IgD−CD38++ plasmablasts following culture is shown (F), as is cell proliferation by carboxyfluorescein diacetate succinimidyl ester dilution (G). There is higher mitochondrial mass in Vav-Atg7−/− B cells, measured by MitoTracker Deep Red and Green (H) and (I), compared with control mice. (A–D) are representative of two independent experiments with n=5 mice per group. (E and G) are representative of three individual healthy donors. (H-I) n=5 per group. *p<0.05; **p<0.01.CC BY · PubMed Central
Figure 6 Effect of in vitro stimulation of human B cells on autophagy. (A) Human B cells were isolated and stimulated with combinations of anti-IgM, anti-CD40 and interferon-α, then stained with CytoID. (B) Annexin V staining in B cells, cultured with and without anti-IgM, and CytoID uptake in cells grouped as annexin V positive or negative (C). (D) Correlation between autophagy activation and cell viability, as assessed by viability dye exclusion. (E) Effect of B cell culture in healthy control or systemic lupus erythematosus patient serum on autophagy. Isolated B cells were cultured in RPMI supplemented with 10% human serum for 4 h, then stained with CytoID. Data illustrate the effects of serum from three patients and three healthy controls. Panels A–E are representative of three or more independent experiments. *p<0.05; **p<0.01; ***p<0.001.
Figure 6 Effect of in vitro stimulation of human B cells on autophagy. (A) Human B cells were isolated and stimulated with combinations of anti-IgM, anti-CD40 and interferon-α, then stained with CytoID. (B) Annexin V staining in B cells, cultured with and without anti-IgM, and CytoID uptake in cells grouped as annexin V positive or negative (C). (D) Correlation between autophagy activation and cell viability, as assessed by viability dye exclusion. (E) Effect of B cell culture in healthy control or systemic lupus erythematosus patient serum on autophagy. Isolated B cells were cultured in RPMI supplemented with 10% human serum for 4 h, then stained with CytoID. Data illustrate the effects of serum from three patients and three healthy controls. Panels A–E are representative of three or more independent experiments. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 252

Metadata

Authors
Clarke, A. J., Ellinghaus, U., Cortini, A., Stranks, A., Simon, A. K., Botto, M., & Vyse, T. J.
Affiliations
  • King's College London (GB)
  • University of Oxford (GB)
  • Imperial College London (GB)
  • Guy's Hospital (GB)
Corresponding author
Vyse, Timothy J
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2015-05
Volume
74
Issue
5
Pages
912-920
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2152993559
Cited by
252
References
43
Citations by year
2026: 10 · 2025: 12 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 18 · 2020: 23 · 2019: 25 · 2018: 21 · 2017: 31 · 2016: 29 · 2015: 16
FWCI
23.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of the Rheumatic Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
Funders
  • Wellcome Trust (WT091013MA, 091013)
  • King's College Hospital NHS Foundation Trust
  • National Institute for Health and Care Research
  • King's College London
  • Biotechnology and Biological Sciences Research Council (BB/G021422/1)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
autophagy, systemic lupus erythematosus, B cell development, plasmablast differentiation, autoreactive B cells, ATG7, autophagy inhibition, autoimmune disease pathogenesis
MeSH terms
Adult, Animals, Autophagy, B-Lymphocytes, Cell Differentiation, Disease Models, Animal, Female, Humans, Lupus Erythematosus, Systemic, Lymphocyte Activation, Male, Plasma Cells, Case-Control Studies, Mice, Precursor Cells, B-Lymphoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. https://app.cochat.ai/papers/10.1136/annrheumdis-2013-204343
The paper
Clarke, A. J., Ellinghaus, U., Cortini, A., Stranks, A., Simon, A. K., Botto, M., & Vyse, T. J. (2015). Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2013-204343

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.